#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile chronic myelomonocytic leukaemia Mastocytosis B-cell lymphoma refractory Brain stem glioma Angiosarcoma recurrent Ocular myasthenia Medulloblastoma Non-small cell lung cancer recurrent Cerebral amyloid angiopathy Familial dilated cardiomyopathy Hereditary angioedema Chordoma Chronic myelomonocytic leukaemia Adenovirus infection Vulval cancer recurrent More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Basic Information Chordoma – Trials in Disease Skin angiosarcoma – Basic Information Bronchopulmonary dysplasia – Diagnostics Primary biliary cholangitis – Basic Information Langerhans cell sarcoma – Trials in Disease Progressive supranuclear palsy – Trials in Disease Alport’s syndrome – Trials in Disease Hereditary angioedema – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Linperlisib IDP-121 Pehero IPN01195 Zoledronic Acid CARBOMER 980 Lysine Acetate GOCATAMIG Pozelimab Elotuzumab Nefopam Lurasidone Technetium (99Mtc) Sufentanil Citrate HALOBETASOL PROPIONATE Fludrocortisone Acetate Doxycycline Monohydrate Ambrosia Artemisiifolia (302) Forimtamig Goserelin Acetate More therapies…

    Learn about Your Condition

    Lymphoedema Spermatocele Neuromuscular scoliosis Peritoneal cancer index Trigeminal neuralgia Mitochondrial myopathy Antithrombin III deficiency Glaucoma Chronic spontaneous urticaria Polymyositis Diabetic foot Periarthritis Pulmonary venous thrombosis Menopause Lichen planopilaris More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Non-small cell lung cancer
    • Renal cell carcinoma
    Investigated Drugs:
    • Pembrolizumab
    France Poland

  • Study on Methotrexate, Dexamethasone, and Montelukast to Prevent Infusion Reactions in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Lazertinib
    • Montelukast Sodium
    • Amivantamab
    France Spain

  • Comparison of Sotorasib versus Docetaxel in Previously Treated Non-Small Cell Lung Cancer Patients with KRAS p.

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sotorasib
    • Dexamethasone
    • Docetaxel
    France Germany Greece Italy The Netherlands Poland +2

  • Study of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Lazertinib
    • Pemetrexed Disodium
    • Amivantamab
    Belgium Bulgaria Czechia Denmark France Germany +6

  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    • Head and neck cancer stage III
    • Head and neck cancer stage IV
    Investigated Drugs:
    • Tisotumab Vedotin
    • Carboplatin
    • Cisplatin
    France Germany Italy Spain

  • Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Hungary +8
Previous Page
1 … 31 32 33 34 35 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!